Obesity drugmakers Eli Lilly (NYSE:LLY) and Novo Nordisk (NVO) traded higher in the premarket on Friday after The Washington ...

Eli Lilly’s trial evaluating Mounjaro in reducing cardiovascular risk met its endpoint, though missed analyst expectations.

These drugs have gained popularity for their ability to reduce body weight by suppressing appetite and slowing digestion.

All the health conditions weight-loss drugs are being used and tested for - Eli Lilly and Novo Nordisk are actively exploring other medical uses for their GLP-1 drugs, and have already seen some succe ...

President Trump has urged major pharmaceutical companies to reduce US prescription drug prices, aligning them with the lowest ...

The 2026 Lilly Endowment Community Scholarship application will open through the Johnson County Community Foundation today.

At their peak last year, one share in the company Novo Nordisk cost $142; now, they can be bought for under $50.